Lama Shamseddine

Lama Shamseddine

Auto-generated profile, based on publicly available information

Lama Shamseddine

Univ. Grenoble Alpes, CEA, CNRS, IBS, Team Bacterial Pathogenesis and Cellular Responses, F-38000 Grenoble, France

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2026
Verified
Thesis
Closed access
LSLama Shamseddine
Lama Shamseddine
Caractérisation des peptides à ponts thioéthers chez Ruminococcus gnavus E1: L'émergence de souches bactériennes résistantes aux antibiotiques est considérée comme l'une desprincipales menaces en santé humaine. Cette situation pousse les scientifiques à trouver de nouvellesmolécules, idéalement naturelles, avec des structures et des modes d'action différents pour contrer lesphénomènes de résistance. Dans ce contexte, les peptides antimicrobiens et notamment les peptidessynthétisés par voie ribosomique et modifiés post-traductionnellement (RiPPs) constituent unealternative prometteuse. Dans ce projet, nous nous sommes concentrés sur les RiPPs contenant desliaisons thioéther. Le travail a porté sur deux types de peptides produits par un membre dominant dumicrobiote intestinal humain, Ruminococcus gnavus E1 : les sactipeptides RumCs et le ranthipeptideRgSCIFF. Les cinq isoformes RumCs (RumC1-5) ont été produits de manière hétérologue, ils présententune structure unique très compacte en double épingle qui leur apporte une grande stabilité. L’étudefonctionnelle montre que les peptides RumCs, à l’xception de RumC2, sont très efficaces contredifférents pathogènes Gram-positif et Gram-négatif. Par ailleurs, ces peptides ne présentent pas detoxicité particulière sur plusieurs cellules eucaryotes. Les peptides RumCs agissent selon un moded’action similaire qui n’implique pas la formation de pores. Par ailleurs, ils sont exclusivement actifs surdes cellules en division et ils inhibent la synthèse de l'ATP. Les travaux en cours visent à déterminer lemode d'action et à identifier la cible cellulaire. Au cours de ce projet, nous avons également mené lacaractérisation biochimique du ranthipeptide RgSCIFF et de l’enzyme radical-SAM associée. De façonintéressante, la forme modifiée du peptide RgSCIFF présente des liaisons thioéther caractéristiques desranthipeptides et des sactipeptides, ce qui en fait le premier exemple de peptide hybride.

15 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LSLama Shamseddine
Lama Shamseddine
MJManon Janet-Maitre
Manon Janet-Maitre
ACAsmaa Yousra Chikhi
Asmaa Yousra Chikhi
HKHarinderbir Kaur
Harinderbir Kaur
JPJean-Luc Pellequer
Jean-Luc Pellequer
VJViviana Job
Viviana Job
The bacterial peptidoglycan (PG) layer is responsible for maintaining cell shape and protecting the cell against both external stress and internal turgor pressure. In rod-shaped bacteria, PG synthesis is orchestrated by two major multi-protein complexes: the elongasome and the divisome, which drive lateral and septal cell wall synthesis, respectively. The membrane protein MreD plays a central role in regulating the elongasome activity. Here, we leveraged a viable Pseudomonas aeruginosa transposon mutant, with reduced mreD expression, to dissect cellular adaptations to impaired elongasome function. A genome-wide synthetic lethality screen revealed that cell division and PG recycling pathways become essential in the context of an impaired elongasome machinery. Moreover, Tn-seq analysis identified the endopeptidase MepM as essential in the mreD downregulated background, whereas its overexpression promoted cell elongation in the parental strain, supporting a conserved role in lateral wall biogenesis. We demonstrate that MepM sustains viability during elongasome impairment by maintaining an active MurU-dependent PG recycling pathway. Together, our findings uncover a functional coupling between PG hydrolysis, recycling, and synthesis. We also identify MepM and PG recycling as critical determinants of bacterial survival when elongasome activity is compromised, positioning these pathways as attractive targets for the development of next-generation or combinatory antibacterial therapies.

16 November 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ABAnne Boyeldieu
Anne Boyeldieu
MVMathilde Vallette
Mathilde Vallette
MBMathieu Bergé
Mathieu Bergé
CRClarisse Roblin
Clarisse Roblin
LSLama Shamseddine
Lama Shamseddine
PPPatrice Polard
Patrice Polard
Ruminoccocin C1 (RumC1) is a structurally unique bacteriocin with broad-spectrum efficacy, including against multidrug-resistant pathogens, yet acting by an undefined mechanism. By integrating genetics, biochemistry, computational modeling, and single-cell fluorescence microscopy, we demonstrate that RumC1 is a distinct cell-wall-targeting toxin. First, all RumC1-resistant mutants isolated through a high-rate, genome-wide mutagenic screening exhibited specific impairments in peptidoglycan homeostasis regulation, pinpointing this pathway as critical for RumC1 activity. Second, RumC1 selectively accumulates within neosynthesized peptidoglycan, leading to cell growth arrest and death in a dose-dependent manner. Third, we characterize the RumI c 1 immunity protein of the RumC1 biosynthetic cluster as a peptidase acting at the cell surface to protect the cells by trimming the stem peptide crucial for cell-wall assembly. As such, RumI c 1 provides cross-protection against vancomycin, while RumC1 is demonstrated to act differently from this glycopeptide antibiotic. Collectively, these findings establish RumC1 as a toxin targeting a key peptidoglycan intermediate of cell wall maturation, which defines a distinct mode of action among the large and highly diverse repertoire of bacteriocins characterized so far.

19 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAnne Boyeldieu
Anne Boyeldieu
MBMathieu Berge
Mathieu Berge
CRClarisse Roblin
Clarisse Roblin
LSLama Shamseddine
Lama Shamseddine
ADAnna M. Diaz-Rovira
Anna M. Diaz-Rovira
PPPatrice Polard
Patrice Polard
RumC1 is a structurally unique bacteriocin with broad-spectrum efficacy, including against multidrug-resistant pathogens, yet acting by an undefined mechanism. By integrating genetics, biochemistry, computational modeling and single-cell fluorescence microscopy, we demonstrate that RumC1 is a distinct cell-wall-targeting toxin. First, all RumC1-resistant mutants isolated through a high-rate, genome-wide mutagenic screening exhibited specific impairments in peptidoglycan homeostasis regulation, pinpointing this pathway as critical for RumC1 activity. Second, RumC1 selectively accumulates within neosynthesized peptidoglycan, leading to cell growth arrest and death in a dose-dependent manner. Third, we characterize the RumIc1 immunity protein of the RumC1 biosynthetic cluster as a peptidase acting at the cell surface to protect the cells by trimming the stem peptide crucial for cell-wall assembly. As such, RumIc1 provides cross-protection against vancomycin, while RumC1 is demonstrated to act differently from this glycopeptide antibiotic. Collectively, these findings establish RumC1 as a toxin targeting a key peptidoglycan intermediate of cell wall maturation.